That post is way off.First off morgan stanley had an appraisal done on the value of insv's deal with inspire. The value came in at $120 million. Morgan stanley put together a deal where insv got a 60 million dollar loan against those future royalties. So if you want to include the debt like your post did you need to put in $120 million for value of inspire deal. Second you give no value for isv-502 which is in phase3, no value for durasite technology or international rights for anything. Most important companies like insv aren't valued off their cash but their drug pipeline